These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30584916)

  • 21. Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes.
    Kooi IE; Mol BM; Massink MP; Ameziane N; Meijers-Heijboer H; Dommering CJ; van Mil SE; de Vries Y; van der Hout AH; Kaspers GJ; Moll AC; Te Riele H; Cloos J; Dorsman JC
    Sci Rep; 2016 Apr; 6():25264. PubMed ID: 27126562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An immature, dedifferentiated, and lineage-deconstrained cone precursor origin of N-Myc-initiated retinoblastoma.
    Singh HP; Shayler DWH; Fernandez GE; Thornton ME; Craft CM; Grubbs BH; Cobrinik D
    Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2200721119. PubMed ID: 35867756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Meta-Analysis of Retinoblastoma Copy Numbers Refines the List of Possible Driver Genes Involved in Tumor Progression.
    Kooi IE; Mol BM; Massink MP; de Jong MC; de Graaf P; van der Valk P; Meijers-Heijboer H; Kaspers GJ; Moll AC; Te Riele H; Cloos J; Dorsman JC
    PLoS One; 2016; 11(4):e0153323. PubMed ID: 27115612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RB1 5́UTR contains an IRES related to cell cycle control and cancer progression.
    Ma W; Ma B; Ma J; Zhu R
    Gene; 2023 Dec; 887():147724. PubMed ID: 37604323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel MYCN-YTHDF1 cascade contributes to retinoblastoma tumor growth by eliciting m
    Luo Y; He M; Yang J; Zhang F; Chen J; Wen X; Fan J; Fan X; Chai P; Jia R
    Sci China Life Sci; 2023 Sep; 66(9):2138-2151. PubMed ID: 36949231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation and characterization of three CRISPR/Cas9 edited RB1 null hiPSC lines for retinoblastoma disease modelling.
    Agrawal T; Maddileti S; Mariappan I
    Stem Cell Res; 2024 Apr; 76():103373. PubMed ID: 38452707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular classification of a complex structural rearrangement of the RB1 locus in an infant with sporadic, isolated, intracranial, sellar region retinoblastoma.
    Schieffer KM; Feldman AZ; Kautto EA; McGrath S; Miller AR; Hernandez-Gonzalez ME; LaHaye S; Miller KE; Koboldt DC; Brennan P; Kelly B; Wetzel A; Agarwal V; Shatara M; Conley S; Rodriguez DP; Abu-Arja R; Shaikhkhalil A; Snuderl M; Orr BA; Finlay JL; Osorio DS; Drapeau AI; Leonard JR; Pierson CR; White P; Magrini V; Mardis ER; Wilson RK; Cottrell CE; Boué DR
    Acta Neuropathol Commun; 2021 Apr; 9(1):61. PubMed ID: 33827698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study on the role of MYCN in retinoblastoma by inhibiting p53 and activating wnt/βcatenin/Fra-1 signaling pathway by reducing DKK3.
    Chen X; Ouyang L; Ke N; Pi L; Zhou X
    Drug Dev Res; 2024 Aug; 85(5):e22222. PubMed ID: 39003564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression.
    Kooi IE; Mol BM; Moll AC; van der Valk P; de Jong MC; de Graaf P; van Mil SE; Schouten-van Meeteren AY; Meijers-Heijboer H; Kaspers GL; Te Riele H; Cloos J; Dorsman JC
    EBioMedicine; 2015 Jul; 2(7):660-70. PubMed ID: 26288838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-Level
    Roohollahi K; de Jong Y; van Mil SE; Fabius AWM; Moll AC; Dorsman JC
    Ophthalmol Sci; 2022 Sep; 2(3):100188. PubMed ID: 36245757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiplex ligation-dependent probe amplification versus fluorescent in situ hybridization for screening
    Eid OM; El Zomor H; Mohamed AM; El-Bassyouni HT; Afifi HH; El-Ayadi M; Sadek SH; Hammad SA; Salem SI; Mahrous R; Fadel IM; Refaat K; Afifi MA; Shelil AE; Ziko OAO; Abdel Azeem AA; El-Haddad A
    Ophthalmic Genet; 2022 Dec; 43(6):789-794. PubMed ID: 36098066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation.
    Qi DL; Cobrinik D
    Oncogene; 2017 Mar; 36(13):1760-1769. PubMed ID: 27748758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Rapid and Sensitive Next-Generation Sequencing Method to Detect RB1 Mutations Improves Care for Retinoblastoma Patients and Their Families.
    Li WL; Buckley J; Sanchez-Lara PA; Maglinte DT; Viduetsky L; Tatarinova TV; Aparicio JG; Kim JW; Au M; Ostrow D; Lee TC; O'Gorman M; Judkins A; Cobrinik D; Triche TJ
    J Mol Diagn; 2016 Jul; 18(4):480-93. PubMed ID: 27155049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics and germline mutation spectrum of RB1 in Chinese patients with retinoblastoma: A dual-center study of 145 patients.
    Chai P; Luo Y; Yu J; Li Y; Yang J; Zhuang A; Fan J; Han M; Jia R
    Exp Eye Res; 2021 Apr; 205():108456. PubMed ID: 33493472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-synonymous, synonymous, and non-coding nucleotide variants contribute to recurrently altered biological processes during retinoblastoma progression.
    Stachelek K; Harutyunyan N; Lee S; Beck A; Kim J; Xu L; Berry JL; Nagiel A; Reynolds CP; Murphree AL; Lee TC; Aparicio JG; Cobrinik D
    Genes Chromosomes Cancer; 2023 May; 62(5):275-289. PubMed ID: 36550020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic profiling reveals the pivotal role of hrHPV driving copy number and gene expression alterations, including mRNA downregulation of TP53 and RB1 in penile cancer.
    Macedo J; Silva E; Nogueira L; Coelho R; da Silva J; Dos Santos A; Teixeira-Júnior AA; Belfort M; Silva G; Khayat A; de Oliveira E; Dos Santos AP; Cavalli LR; Pereira SR
    Mol Carcinog; 2020 Jun; 59(6):604-617. PubMed ID: 32212199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterozygous RB1 mutation enhanced ATP production in human iPSC-derived retinal organoids.
    Vincent A; Krishnakumar S; Parameswaran S
    Mol Biol Rep; 2024 May; 51(1):606. PubMed ID: 38704498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CDK4 inhibition restores G(1)-S arrest in MYCN-amplified neuroblastoma cells in the context of doxorubicin-induced DNA damage.
    Gogolin S; Ehemann V; Becker G; Brueckner LM; Dreidax D; Bannert S; Nolte I; Savelyeva L; Bell E; Westermann F
    Cell Cycle; 2013 Apr; 12(7):1091-104. PubMed ID: 23462184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinoblastoma patient-derived stem cells-an in vivo model to study the role of RB1 in adipogenesis.
    Vincent A; Natarajan V; Khetan V; Krishnakumar S; Parameswaran S
    Histochem Cell Biol; 2022 Aug; 158(2):181-192. PubMed ID: 35445864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterozygous retinoblastoma gene mutation compromises in vitro osteogenesis of adipose mesenchymal stem cells - a temporal gene expression study.
    Vincent A; Natarajan V; Khetan V; Krishnakumar S; Parameswaran S
    Exp Cell Res; 2020 Nov; 396(1):112263. PubMed ID: 32890459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.